|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) through any online brokerage.
The latest price target for Alnylam Pharmaceuticals (NASDAQ: ALNY) was reported by Goldman Sachs on November 22, 2021. The analyst firm set a price target for 273.00 expecting ALNY to rise to within 12 months (a possible 59.31% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $171.36 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Alnylam Pharmaceuticals.
Alnylam Pharmaceuticals’s $Q4 earnings are confirmed for after-market on February 10, 2022.
There is no upcoming split for Alnylam Pharmaceuticals.
Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.